← Back to Search

Tissue Adhesive

1 for Wound

Phase 2
Waitlist Available
Led By Firoz Miyanji, MD, FRCSC
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks after surgery
Awards & highlights

Study Summary

This is a prospective, Phase II (hypothesis generating) randomized pilot study investigating the efficacy of using Dermabond as a method of final wound closure as compared to the standard staple method in children with Neuromuscular Scoliosis undergoing spinal deformity correction surgery.

Eligible Conditions
  • Wound

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day of surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and day of surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in the incidence of wound infection in Dermabond group versus the skin staple group
Secondary outcome measures
Difference in mean caregiver/parental satisfaction scores as measured by a visual analog scale
Difference in the cosmetic result of the wound closure as measured by the Hollander wound evaluation scale
Difference in the time for final wound closure

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
2-octylcyanoacrylate (Dermabond) closure
Group II: 2Active Control1 Intervention
Standard staple closure

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,936 Total Patients Enrolled
BCCH Telethon GrantUNKNOWN
Firoz Miyanji, MD, FRCSCPrincipal InvestigatorUniversity of British Columbia
1 Previous Clinical Trials
10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025